Everpure, Inc. (NYSE: P) saw its shares climb 2.2% in after-hours trading on Friday, adding roughly $723 million to its market capitalization after the data-storage company was selected for inclusion in the S&P 500 index. The stock closed the regular session at $99.51, then jumped to $102.90 shortly after the announcement at 5:15 p.m. EDT before settling at $101.68 by 6:28 p.m. EDT.
The late-session move extended Friday's total gain to 3.6%, lifting the company's implied equity value by $1.18 billion from Thursday's close of $98.15. The bulk of that increase—$723 million—came after the bell, driven by index funds that must adjust their portfolios ahead of the September 21 effective date.
Index Inclusion Mechanics
S&P Dow Jones Indices announced the change at 5:15 p.m. EDT, revealing that Everpure will replace The Trade Desk, Inc. (NASDAQ: TTD) in the S&P 500. Corcept Therapeutics Incorporated (NASDAQ: CORT) will take Everpure's place in the S&P MidCap 400. The rebalance is scheduled to take effect before trading opens on September 21.
While the market reaction was immediate, the exact buying pressure remains uncertain. S&P did not disclose Everpure's final index weight or the number of shares that benchmark-tracking funds will need to purchase. Using the 333.23 million shares outstanding reported in Everpure's latest quarterly filing, the after-hours move alone created approximately $723 million in new equity value.
Strong Revenue Growth, Cash Flow Concerns
The index promotion comes on the heels of Everpure's fiscal second-quarter results, which showed revenue surging 38% year-over-year to $1.186 billion. Product sales jumped 54%, while subscription-services revenue grew 20%. The company also reported contracted business expansion, with remaining performance obligations reaching $4.1 billion, up 44%.
Management credited artificial intelligence and hyperscale product demand as key growth drivers. CEO Charles Giancarlo noted that the quarter marked "eight straight quarters of accelerating revenue growth." The company raised its full-year revenue guidance to $5.03-$5.07 billion, up from the prior range of $4.41-$4.51 billion.
However, the cash flow picture tells a different story. Operating cash flow swung to negative $136.3 million from positive $212.2 million a year earlier. Capital expenditures rose to $101.3 million from $62.0 million, pushing free cash flow to negative $237.6 million—a stark reversal from the $150.1 million positive figure in the same quarter last year.
Valuation and Analyst Sentiment
At the after-hours price of $101.68, Everpure's market capitalization stands at approximately $33.88 billion, implying a price-to-sales multiple of 6.7 times management's guided midpoint. That valuation leaves little room for error, especially given the cash flow deterioration.
Wall Street remains largely bullish, with StockAnalysis data showing 13 Strong Buy ratings, five Buys, one Hold, and one Strong Sell. The average analyst price target of $130.53 implies 28.4% upside from Friday's late quote. However, targets range widely from $80 at UBS to $150 at BofA, reflecting the ongoing debate about hyperscale growth sustainability and valuation.
What's Next
The September 21 index rebalance has a fixed date, but the company's cash conversion story is less certain. Investors will be watching upcoming quarterly reports to see whether the negative free cash flow is a temporary blip or a more persistent trend. The index premium may fade after the rebalance, and large customer orders can be uneven, potentially affecting demand.
Everpure's next earnings report will be crucial in determining whether the market's enthusiasm is justified. The company's ability to convert its rapid growth into positive cash flow will be a key test for the stock's new index-level valuation.
